This trial is no longer available!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Rheumatoid Arthritis
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

An expanded access trial of belimumab for named patients who participated in LBRA99.

Provided treatments

  • Drug: belimumab
Tris trial is registered with FDA with number: NCT00931086. The sponsor of the trial is Human Genome Sciences Inc., a GSK Company and it is looking for 0 volunteers for the current phase.
Official trial title:
An Expanded Access Trial of Belimumab Antibody (Monoclonal Anti-BLyS Antibody) in Patients With Rheumatoid Arthritis (RA) Who Were Previously Treated Under HGS Protocol LBRA99